Gamallat, Y.; Felipe Lima, J.; Seyedi, S.; Li, Q.; Rokne, J.G.; Alhajj, R.; Ghosh, S.; Bismar, T.A.
Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer. Cancers 2024, 16, 1436.
https://doi.org/10.3390/cancers16071436
AMA Style
Gamallat Y, Felipe Lima J, Seyedi S, Li Q, Rokne JG, Alhajj R, Ghosh S, Bismar TA.
Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer. Cancers. 2024; 16(7):1436.
https://doi.org/10.3390/cancers16071436
Chicago/Turabian Style
Gamallat, Yaser, Joema Felipe Lima, Sima Seyedi, Qiaowang Li, Jon George Rokne, Reda Alhajj, Sunita Ghosh, and Tarek A. Bismar.
2024. "Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer" Cancers 16, no. 7: 1436.
https://doi.org/10.3390/cancers16071436
APA Style
Gamallat, Y., Felipe Lima, J., Seyedi, S., Li, Q., Rokne, J. G., Alhajj, R., Ghosh, S., & Bismar, T. A.
(2024). Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer. Cancers, 16(7), 1436.
https://doi.org/10.3390/cancers16071436
